4.1 Article

Identification of a cannabimimetic indole as a designer drug in a herbal product

Journal

FORENSIC TOXICOLOGY
Volume 27, Issue 2, Pages 61-66

Publisher

SPRINGER
DOI: 10.1007/s11419-009-0069-y

Keywords

1-Pentyl-3-(1-naphthoyl)indole; Naphthalen-1-yl-(1-pentylindol-3-yl)methanone; JWH-018; Cannabimimetic indole; Designer drug; Herbal product

Categories

Funding

  1. Ministry of Health, Labour, and Welfare of Japan

Ask authors/readers for more resources

A cannabimimetic indole has been identified as a new adulterant in a herbal product being sold illegally in Japan for its expected narcotic effect. Liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry analyses indicated that the product contained two major compounds. One was identified as a cannabinoid analog (1RS,3SR)-3-[4-(1,1-dimethyloctyl)-2-hydroxyphenyl]cyclohexan-1-ol (1) by direct comparison with the authentic compound, which we reported previously. The other compound (2) showed a molecular weight of 341 daltons, and accurate mass spectral measurements showed its elemental composition to be C24H23NO. Both mass and nuclear magnetic resonance spectrometric data revealed that 2 was 1-pentyl-3-(1-naphthoyl)indole [or naphthalen-1-yl-(1-pentylindol-3-yl)methanone] being identical to JWH-018, which was synthesized by Wiley and coworkers in 1998. This compound was reported as a potent cannabinoid receptor agonist possessing a pharmacological cannabimimetic activity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available